David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.
Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.
Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
A coalition of life sciences lobbying groups bands together to demand more clarity from laws aiming to add transparency to physician-industry relationships.
Medicare's Sunshine Act database is slated to go public later this month with a year's worth of data on industry relationships with physicians, but an alliance of life sciences groups is calling for some sunshine of its own.
Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark for Vercise brain stim device; 20 Years of Improving Women's Health; Medtronic wins CE Mark for Tyrx cardiac device envelope; VertiFlex lands FDA panel date for Superion interspinous spacer